Learn More
BioVendor, LLC Mmp-9 Human Elisa BioVendor LLC

Supplier: BioVendor, LLC RBL002R
Increased matrix metalloprotease 9 (MMP9), also called Gelatinase B, after myocardial infarction (MI) exacerbates ischemia-induced chronic heart failure (CHF). It is also upregulated in the diabetic heart, and ablation of MMP9 decreases infarct size in the non-diabetic myocardial infarction heart.3 There is also strong evidence that the increased levels of MMP-9 are associated with many inflammatory conditions, such as coronary artery disease, COPD, arthritis, and metabolic syndrome. It was also proved that MMP-9 is associated with progression of atherosclerosis and higher risk of cardiovascular events. It was also suggested that elevated levels of MMP-9 (combined with MMP-2) are associated with highly tumorigenic cancers. One kit (96 wells). Type: sandwich ELISA. Sample type: serum, plasma. Sample req: 5 ¿l/well. Cal range: 0.625-20ng/ml. LoD: 0.16ng/ml. Other names: Matrix Metalloproteinase-9, MMP9.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.